A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Inflammation in the brain plays a major role in neurodegenerative diseases. In particular, microglial cell activation is believed to be associated with the pathogenesis of neurodegenerative diseases, including Parkinson's disease (PD). An increase in microglia activation has been shown in the substantia nigra pars compacta (SNpc) of PD models when there has been a decrease in tyrosine hydroxylase (TH) positive cells. This may be a sign of neurotoxicity due to prolonged activation of microglia in both early and late stages of disease progression. Natural products, such as spirulina, derived from blue green algae, are believed to help reverse this effect due to its anti-inflammatory/anti-oxidant properties. An adeno-associated virus vector (AAV9) for α-synuclein was injected in the substantia nigra of rats to model Parkinson's disease and to study the effects of spirulina on the inflammatory response. One month prior to surgeries, rats were fed either a diet enhanced with spirulina or a control diet. Immunohistochemistry was analyzed with unbiased stereological methods to quantify lesion size and microglial activation. As hypothesized, spirulina was neuroprotective in this α-synuclein model of PD as more TH+ and NeuN+ cells were observed; spirulina concomitantly decreased the numbers of activated microglial cells as determined by MHCII expression. This decrease in microglia activation may have been due, in part, to the effect of spirulina to increase expression of the fractalkine receptor (CX3CR1) on microglia. With this study we hypothesize that α-synuclein neurotoxicity is mediated, at least in part, via an interaction with microglia. We observed a decrease in activated microglia in the rats that received a spirulina- enhanced diet concomitant to neuroprotection. The increase in CX3CR1 in the groups that received spirulina, suggests a potential mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Effect of spirulina on TH immunoreactive cells in the SNpc. TH positive cells in the SNpc after 1 or 4 months of α-synuclein expression. Cells were counted using unbiased stereological counting techniques. (A) One month after α-synuclein gene transfer, there was a significant decrease in TH positive cells as compared to GFP control (N = 12–18/group). The spirulina diet group lesioned with α-synuclein (N = 12) had greater numbers of TH positive cells compared to the control diet group lesioned with α-synuclein (N = 18). There was a diet by vector group interaction in the two way ANOVA analysis [F = 5.569, p<0.01]. (B) Results at four months were similar. There was a similar loss of TH positive cells and protective effect of spirulina. Two-way ANOVA yielded a main effect of diet (F = 81.3), and a main effect of vector group (F = 45.5; p<0.01), although without a significant interaction. Bonferonni post-hoc tests comparing NIH 31 GFP (N = 10) vs NIH 31 synuclein (N = 8) and NIH31 synuclein vs spirulina synuclein (N = 8) groups were significant). Asterisk denotes significance (*P<0.05; **p<0.01).](https://figures.cochat.ai/paper-figures/2819f8272f0842d2904977d041ee6d23/a-spirulina-enhanced-diet-provides-neuroprotection-in-an-synuclein-model-of-figure-1.jpg)
![Figure 2 Effect of spirulina on NeuN immunoreactive cells in the SNpc. NeuN positive cells in the SNpc after 1 or 4 months of α-synuclein expression. At 1 month, there was a decrease in NeuN positive cells in the SN, mirroring the loss of TH positive cells in Fig. 1. This confirms cell loss rather than loss of TH expression. The effect was similar at 4 months of expression (B). There was neuroprotection in the groups that received a diet enhanced with spirulina at both intervals. Two-way ANOVA yielded a significant interaction of diet and vector treatment at both time points [1 month F = 6.931, df = 1; 4 months F = 8.899 df = 1]. (*p<0.05; **p<0.01) after Bonferonni's post-hoc.](https://figures.cochat.ai/paper-figures/1f2c1055f07f4a719d00e0681c242475/a-spirulina-enhanced-diet-provides-neuroprotection-in-an-synuclein-model-of-figure-2.jpg)
![Figure 3 Effect of spirulina on OX-6 positive staining. There was a decrease in OX-6 positive staining in the groups that received spirulina at both 1 (A) and 4 (B) months of α-synuclein expression as compared to the control groups. Two-way ANOVA was performed for both 1 and 4 month groups and showed a significant interaction between diet and vector treatment [1 month F = 5.592, df = 1] and [4 months F = 8.899, df = 1]. Bonferonni post hoc analysis for individual comparisons is shown (*p<0.05, and ***p<0.001).](https://figures.cochat.ai/paper-figures/3e37267e588c4a6e83fd30446ec7c9ee/a-spirulina-enhanced-diet-provides-neuroprotection-in-an-synuclein-model-of-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some authors have reported that Arthrospira platensis supports the resistance to the oxidative aspect of microglial cell activity and fights against memory loss [92,93].”
From Application of Arthrospira platensis for Medicinal Purposes and the Food Industry: A Review of the Literature (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and activation of microglial cells is thought to be involved in the pathogenesis of neurodegenerative diseases [88].”
From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proceedings of the National Academy of Sciences of the United States of America
Dowling, J. E., & Wald, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06752.x · Cited by 17,893
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“In some forms of familial PD the asynuclein gene is triplicated or carries a missense mutation [10,11,11–13].”
Backgroundα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 3×
“CX3CR1 is a chemokine receptor that when stimulated, leads to reduced synthesis of pro-inflammatory cytokines IL1b and TNFa [29].”
BackgroundZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“CX3CL1 and CX3CR1 are normally expressed at relatively high levels in the brain [29,40] but decrease during aging, and may be involved in neurodegenerative diseases [29].”
BackgroundClades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070 · cited 1×
“Since its discovery in 2004 by Gao and colleagues [25], the AAV9 vector variant has proven to be efficient for neuronal gene transfer [26,27].”
BackgroundKirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649 · cited 1×
“AAV vector gene transfer of a-synuclein has established a progressive loss of DA neurons in the SN [12,24] that may be more relevant to PD pathogenesis than more rapid neurotoxin models.”
BackgroundSynuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474 · cited 1×
“was observed [30].”
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439 · cited 1×
“An increase in numbers of microglia and the presence of activated microglia has been noted in several studies and they are present in both early and late stages of the disease [4–6].”
BackgroundNeuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Gao, H.-M., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 436
Cearley, C. N., & Wolfe, J. H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.015 · Cited by 409 · cited 1×
“Since its discovery in 2004 by Gao and colleagues [25], the AAV9 vector variant has proven to be efficient for neuronal gene transfer [26,27].”
BackgroundAntioxidant activity of the microalga Spirulina maxima
Miranda, M. S., Cintra, R. G., Barros, S. B. M., & Mancini-Filho, J. (1998) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1998000800007 · Cited by 389 · cited 1×
“Extracts of spirulina have antioxidant activity both in vivo and in vitro [21].”
BackgroundSelective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis
Reddy, C. M., Bhat, V. B., Kiranmai, G., Reddy, M. N., Reddanna, P., & Madyastha, K. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3725 · Cited by 310 · cited 2×
“Spirulina, a type of blue green algae that has been consumed for thousands of years as a primary food source for the Aztecs and Mayans, contains high levels of antioxidant and anti-inflammatory phytochemicals; for example carotenoids [18], especially beta-carotene [19], phycocyanin and phycocyanobilin [20].”
BackgroundBhat, V. B., & Madyastha, K. M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5195 · Cited by 277 · cited 1×
“Phycocyanin and phycocyanobilin in spirulina were found to have strong anticyclooxygenase-2 and antioxidant activity [20,22].”
BackgroundToll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
Stefanova, N., Fellner, L., Reindl, M., Masliah, E., Poewe, W., & Wenning, G. K. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.013 · Cited by 272 · cited 1×
“In addition, several papers suggest toll like receptor expression is involved in a-syncleinopathy [32,33], and asynuclein has been shown to modulate the microglial phenotype [34].”
BackgroundNitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease
Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo‐Dukelow, M., Chaudhuri, A., Ciborowski, P., Cerny, R., Gelman, B., Thomas, M. P., Mosley, R. L., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 244 · cited 1×
“Aside from the dramatic loss of dopaminergic neurons associated with PD, it has been shown that the substantia nigra (SN) is also the site of a robust glial reaction in PD with1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) poisoning [1] and in response to a-synuclein [2–3].”
BackgroundCX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease
Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., & Bickford, P. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-9 · Cited by 241 · cited 1×
“We believe this could be one aspect of the mechanism of action of spirulina in this study as we have previously demonstrated that increasing CX3CL1 is neuroprotective in a 6-OHDA model of PD [41].”
BackgroundSelf-citationDietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage
Wang, Y., Chang, C.-F., Chou, J., Chen, H.-L., Deng, X., Harvey, B. K., Cadet, J. L., & Bickford, P. C. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.014 · Cited by 223 · cited 1×
“Spirulina has also been shown to be neuroprotective in a 6-OHDA model of PD [23], and in other models of CNS neurodegeneration [36].”
BackgroundSelf-citationDopaminergic Cell Loss Induced by Human A30P α -Synuclein Gene Transfer to the Rat Substantia Nigra
Klein, R. L., King, M. A., Hamby, M. E., & Meyer, E. M. (2002) · Human Gene Therapy · doi:10.1089/10430340252837206 · Cited by 211 · cited 1×
“AAV vector gene transfer of a-synuclein has established a progressive loss of DA neurons in the SN [12,24] that may be more relevant to PD pathogenesis than more rapid neurotoxin models.”
BackgroundSelf-citationBhat, V. B., & Madyastha, K. M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5368 · Cited by 206
α-Synuclein Alters Toll-Like Receptor Expression
Béraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., & Maguire-Zeiss, K. A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00080 · Cited by 198
Klein, R. L., Dayton, R. D., Tatom, J. B., Henderson, K. M., & Henning, P. P. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300331 · Cited by 196
Self-citationAlpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
Alvarez-Erviti, L., Couch, Y., Richardson, J., Cooper, J. M., & Wood, M. J. A. (2011) · Neuroscience Research · doi:10.1016/j.neures.2010.12.020 · Cited by 193 · cited 1×
“Extracellular release of a-synuclein is paralleled by increases in pro-inflammatory cytokine and ROS production damaging not only the afflicted neurons of the SNpc but the surrounding milieu [15].”
BackgroundCareri, M., Furlattini, L., Mangia, A., Musci, M., Anklam, E., Theobald, A., & von Holst, C. (2001) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)00545-3 · Cited by 192 · cited 1×
“Spirulina, a type of blue green algae that has been consumed for thousands of years as a primary food source for the Aztecs and Mayans, contains high levels of antioxidant and anti-inflammatory phytochemicals; for example carotenoids [18], especially beta-carotene [19], phycocyanin and phycocyanobilin [20].”
BackgroundLo Bianco, C., Shorter, J., Régulier, E., Lashuel, H., Iwatsubo, T., Lindquist, S., & Aebischer, P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35781 · Cited by 190 · cited 1×
“However, Parkin and HSP104 have shown efficacy [45,46].”
BackgroundGDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
Decressac, M., Ulusoy, A., Mattsson, B., Georgievska, B., Romero-Ramos, M., Kirik, D., & Bjorklund, A. (2011) · Brain · doi:10.1093/brain/awr149 · Cited by 178 · cited 1×
“The a-synuclein model of PD has been shown to replicate the human pathology more closely than other models [42] Interestingly not all therapeutic interventions that work in other models have been successful in a-synuclein induced models of PD, for example GDNF failed to protect [43,44] against either WT a synuclien or…”
BackgroundDecressac, M., Mattsson, B., & Björklund, A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.02.012 · Cited by 174 · cited 1×
“The a-synuclein model of PD has been shown to replicate the human pathology more closely than other models [42] Interestingly not all therapeutic interventions that work in other models have been successful in a-synuclein induced models of PD, for example GDNF failed to protect [43,44] against either WT a synuclien or…”
BackgroundGlial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
Fellner, L., Jellinger, K. A., Wenning, G. K., & Stefanova, N. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0833-z · Cited by 162 · cited 1×
“neurons and glia in PD patients and it can later be released into the extracellular space leading to further inflammation [35].”
BackgroundCouch, Y., Alvarez-Erviti, L., Sibson, N. R., Wood, M. J., & Anthony, D. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-166 · Cited by 155 · cited 1×
“does so in a specific and powerful manner as a result of systemic events [7].”
BackgroundFamilial parkinsonism with synuclein pathology: Clinical and PET studies of A30P mutation carriers
Krüger, R., Kuhn, W., Leenders, K. L., Sprengelmeyer, R., Müller, T., Woitalla, D., Portman, A. T., Maguire, R. P., Veenma, L., Schröder, U., et al. (2001) · Neurology · doi:10.1212/wnl.56.10.1355 · Cited by 154
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
Su, X., Federoff, H. J., & Maguire-Zeiss, K. A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9053-x · Cited by 145 · cited 2×
“Furthermore, several studies have shown that a-synuclein directly activates microglia in cell culture [31,32].”
BackgroundShih, S., Tsai, K., Li, Y., Chueh, C., & Chan, E. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10363 · Cited by 145 · cited 1×
“One possible explanation for the neuroprotective effect of spirulina is that it contains phycocyanin which has been shown to inhibit cyclooxygenase 2 [37] and it has been shown that a-synuclein increases cyclooxygenase 2 expression [34]; however there are many active components in spirulina and several of these may in…”
Backgroundα-Synuclein Expression Modulates Microglial Activation Phenotype
Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1799-06.2006 · Cited by 142 · cited 1×
“Aside from the dramatic loss of dopaminergic neurons associated with PD, it has been shown that the substantia nigra (SN) is also the site of a robust glial reaction in PD with1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) poisoning [1] and in response to a-synuclein [2–3].”
BackgroundVimentin immunoreactivity in normal and pathological human brain tissue
Yamada, T., Kawamata, T., Walker, D. G., & McGeer, P. L. (1992) · Acta Neuropathologica · doi:10.1007/bf00311389 · Cited by 132 · cited 1×
“Lewy bodies are intracytoplasmic structures containing aggregated a-synuclein; however, it has been shown that these structures can be also found extracellularly and are surrounded by activated microglia and components of the complement system [9,14].”
BackgroundLo Bianco, C., Déglon, N., Pralong, W., & Aebischer, P. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.008 · Cited by 129 · cited 1×
“The a-synuclein model of PD has been shown to replicate the human pathology more closely than other models [42] Interestingly not all therapeutic interventions that work in other models have been successful in a-synuclein induced models of PD, for example GDNF failed to protect [43,44] against either WT a synuclien or…”
BackgroundStrömberg, I., Gemma, C., Vila, J., & Bickford, P. C. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.013 · Cited by 118 · cited 3×
“Previous studies with diets enriched with blueberries or spirulina were shown to enhance the recovery of striatal dopamine TH positive fibers and TH positive neurons in the SNpc following an intrastriatal 6-OHDA lesion model of PD [23].”
BackgroundResultInfluentialSelf-citationParkin Gene Therapy for α-Synucleinopathy: A Rat Model of Parkinson's Disease
Yamada, M., Mizuno, Y., & Mochizuki, H. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.262 · Cited by 116 · cited 1×
“However, Parkin and HSP104 have shown efficacy [45,46].”
BackgroundExpression of mutant alpha-synuclein modulates microglial phenotype in vitro
Rojanathammanee, L., Murphy, E. J., & Combs, C. K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-44 · Cited by 106
Zujovic, V., Schussler, N., Jourdain, D., Duverger, D., & Taupin, V. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00259-4 · Cited by 102 · cited 2×
“CX3CL1 acts in vitro as an anti-inflammatory molecule by down regulating levels of IL-1b, TNF-a and, IL-6 [38,39].”
BackgroundParkin gene therapy for α-synucleinopathy : a rat model of Parkinson's disease
山田, 正. (2005) · Medical Entomology and Zoology · Cited by 101
The role of the immune system in neurodegenerative disorders
McGeer, E. G., & McGeer, P. L. (1997) · Movement Disorders · doi:10.1002/mds.870120604 · Cited by 98 · cited 1×
“An increase in numbers of microglia and the presence of activated microglia has been noted in several studies and they are present in both early and late stages of the disease [4–6].”
BackgroundSpirulina as a source of vitamin A
Annapurna, V., Deosthale, Y. G., & Bamji, M. S. (1991) · Plant Foods for Human Nutrition · doi:10.1007/bf02194081 · Cited by 75 · cited 1×
“Spirulina, a type of blue green algae that has been consumed for thousands of years as a primary food source for the Aztecs and Mayans, contains high levels of antioxidant and anti-inflammatory phytochemicals; for example carotenoids [18], especially beta-carotene [19], phycocyanin and phycocyanobilin [20].”
BackgroundMagrone, T., Marzulli, G., & Jirillo, E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919057 · Cited by 51 · cited 1×
“Vitamin D and polyphenols have been used to inhibit ROS formation and decrease cytokine-mediated neuroinflammation in PD models [17].”
BackgroundQualitative versus quantitative caloric intake: are they equivalent paths to successful aging?
Casadesús, G., Shukitt‐Hale, B., & JOSEPH, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00079-9 · Cited by 43 · cited 1×
“maximal lifespan [16].”
Early inhibition of TNFα increases 6-hydroxydopamine-induced striatal degeneration
Gemma, C., Catlow, B. J., Cole, M., Hudson, C., Samec, A. M., Shah, N. K., Vila, J., Bachstetter, A. D., & Bickford, P. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.003 · Cited by 28
Self-citationWest, M. J. (2001) · PubMed · Cited by 13
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Zujovic (2000) · doi:10.1002/(sici)1098-1136(20000215)29:4
Cited by
The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview
Wu, Q., Liu, L., Miron, A., Klímová, B., Wan, D., & Kuča, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1744-5 · Cited by 655
The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments
Sanchez-Guajardo, V., Tentillier, N., & Romero-Ramos, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.008 · Cited by 172
Furmaniak, M. A., Misztak, A. E., Franczuk, M. D., Wilmotte, A., Waleron, M., & Waleron, K. F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02541 · Cited by 121
“Another animal study demonstrates “Spirulina”’s ability to protect neurons in the αsynuclein model of Parkinson Disease (Pabon et al., 2012).”
BackgroundFractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration
Nash, K. R., Moran, P., Finneran, D. J., Hudson, C., Robinson, J., Morgan, D., & Bickford, P. C. (2015) · Molecular Therapy · doi:10.1038/mt.2014.175 · Cited by 108
“Surgery was performed as described previously [33, 49].”
MethodSelf-citationGentscheva, G., Nikolova, K., Panayotova, V., Peycheva, K., Makedonski, L., Slavov, P., Radusheva, P., Petrova, P., & Yotkovska, I. (2023) · Life · doi:10.3390/life13030845 · Cited by 106
Metadata
- Authors
- Pabon, M. M., Jernberg, J. N., Morganti, J., Contreras, J., Hudson, C. E., Klein, R. L., & Bickford, P. C.
- Affiliations
- University of South Florida (US)
- Tulane University (US)
- James A. Haley Veterans' Hospital (US)
- Louisiana State University Health Sciences Center Shreveport (US)
- Corresponding author
- Bickford, Paula C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-18
- Volume
- 7
- Issue
- 9
- Pages
- e45256
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3445455
- OpenAlex
- W2070772378
- Cited by
- 90
- References
- 49
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 7 · 2019: 8 · 2018: 2 · 2017: 3 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 3
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Spirulina, Parkinson's disease, alpha-synuclein, microglial activation, neuroprotection, substantia nigra pars compacta, adeno-associated virus vectors, AAV9, tyrosine hydroxylase, MHC class II, CX3CR1, neuroinflammation, dietary supplementation, neurodegeneration
- MeSH terms
- CX3C Chemokine Receptor 1, Dependovirus, Animals, Histocompatibility Antigens Class II, Diet, Disease Models, Animal, Gene Expression Regulation, Injections, Intraventricular, Male, Parkinson Disease, Secondary, Substantia Nigra, Tyrosine 3-Monooxygenase, Microglia, Neuroprotective Agents, Receptors, Chemokine, Rats, alpha-Synuclein, Spirulina
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.